Administration of recombinant human IL11 after supralethal radiation exposure promotes survival in mice: interactive effect with thrombopoietin
about
sameAs
Effects of Designer Hyper-Interleukin 11 (H11) on Hematopoiesis in Myelosuppressed MiceThe radiation protection and therapy effects of mesenchymal stem cells in mice with acute radiation injury.Strain-specific susceptibility for pulmonary metastasis of sarcoma 180 cells in inbred mice.PEGylated G-CSF (BBT-015), GM-CSF (BBT-007), and IL-11 (BBT-059) analogs enhance survival and hematopoietic cell recovery in a mouse model of the hematopoietic syndrome of the acute radiation syndrome.Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling.Oral interleukin 11 as a countermeasure to lethal total-body irradiation in a murine model.Attenuation of radiation-induced gastrointestinal damage by epidermal growth factor and bone marrow transplantation in mice.Further Characterization of the Mitigation of Radiation Lethality by Protective Wounding.Multiplacenta derived stem cell/cytokine treatment increases survival time in a mouse model with radiation-induced bone marrow damage.
P2860
Q33431967-4D82CA6B-766D-4113-AA0B-31A8AAFEC399Q36365954-0A4A19B9-D065-4B2B-B529-2572CC993F71Q36403393-F966DBDF-68B8-4F88-A20A-5FE2CCE95E46Q37349170-EA56705B-9AD6-4952-809F-BE0E25652233Q37409325-F3F171C7-7083-43D3-83BB-AC704D0B078CQ39855237-25E50469-98A4-409A-B716-AAF15E51B350Q40917982-B89E6995-9D95-4556-AB47-A0ADA97B017CQ47784514-285A5493-4C35-4BE6-84C3-ED51C5AF5182Q50233609-1E7B4576-53C4-4D79-B2D2-001BC7A42EF4
P2860
Administration of recombinant human IL11 after supralethal radiation exposure promotes survival in mice: interactive effect with thrombopoietin
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Administration of recombinant ...... ive effect with thrombopoietin
@ast
Administration of recombinant ...... ive effect with thrombopoietin
@en
Administration of recombinant ...... ive effect with thrombopoietin
@nl
type
label
Administration of recombinant ...... ive effect with thrombopoietin
@ast
Administration of recombinant ...... ive effect with thrombopoietin
@en
Administration of recombinant ...... ive effect with thrombopoietin
@nl
prefLabel
Administration of recombinant ...... ive effect with thrombopoietin
@ast
Administration of recombinant ...... ive effect with thrombopoietin
@en
Administration of recombinant ...... ive effect with thrombopoietin
@nl
P2093
P3181
P1433
P1476
Administration of recombinant ...... ive effect with thrombopoietin
@en
P2093
Anne Van der Meeren
Marc-André Mouthon
Marie Vandamme
Marie-Hélène Gaugler
Patrick Gourmelon
P3181
P356
10.1667/0033-7587(2002)157[0642:AORHIA]2.0.CO;2
P407
P577
2002-06-01T00:00:00Z